5 Israeli cos win Frost & Sullivan awards

Two Israeli companies made the World Economic Forum’s “Technology Pioneers 2007” list.

Five Israeli companies have won this year’s Frost & Sullivan Emerging Technologies Award, out of 24 European winners. The other winners are six companies from the UK, four from Germany, two from Switzerland, and one each from Belgium, Finland, Ireland, Italy, the Netherlands, and Sweden.

The Israeli winners are as follows:

  • OrSense, which won the 2006 Technology Innovation Award for its NBM-200 non-invasive monitor of blood glucose and other analyte concentrations.
  • Glycominds Ltd., which won the 2006 Technology Innovation Award for its tools that use biomarkers to monitor types of sugars in the blood for Inflammatory Bowel Disease diagnostics and Crohn's disease severity prediction.
  • Trig Medical Inc., which won the 2006 European Technology Innovation of the Year Award in the Labor Monitoring Technologies for its software labor monitoring system that integrates ultrasound and foetal monitoring technology to provide non-invasive determination of foetal head station and position.
  • Convergin Ltd., which won the 2006 Product Innovation Award for its wireless convergence server platform.
  • NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE), which won the 2006 Excellence in Technology Award for its voice video surveillance security solutions.

The awards will be distributed tonight.

The companies said the Frost & Sullivan innovation awards were awarded to companies conducting innovative research that leads to the development of products likely to make a significant contribution to industry. In picking the winners, Frost & Sullivan takes into consideration the quality of the company’s R&D, as well as the vision and level of risk taking that made the breakthrough possible.

In a separate development, the World Economic Forum has included two Israeli companies in its “Technology Pioneers 2007” list. 47 companies made the list. The Israeli companies are Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN), which develops and markets diagnostic endoscopic capsules; and Brainsgate, which offers an implantable medical device for treatment of diseases of the brain and central nervous system.

Published by Globes [online], Israel business news - www.globes.co.il - on December 5, 2006

© Copyright of Globes Publisher Itonut (1983) Ltd. 2006

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018